VITAMINS. PREVENTION AND TREATMENT OF COMPLICATIONS IN PATIENTS WITH DIABETES MELLITUS
https://doi.org/10.21518/2079-701X-2017-3-95-98
Abstract
Hyperglycemia is a major cause of complications in patients with diabetes mellitus (DM). Since the optimal level of glycemic control is achieved only in a small number of patients with diabetes mellitus, additional methods of prevention and treatment of complications are strongly recommended. The focus of healthcare specialists is increasing on substances that can affect intracellular pathological processes associated with hyperglycemia. Such drugs or agents include certain vitamins and minerals.
About the Author
S. V. Podachina
Moscow State University of Medicine and Dentistry named after A.I. Evdokimov
Russian Federation
Russian Federation
References
1. Сахарный диабет: острые и хронические осложнения. Под ред. И.И. Дедова, М.В. Шестаковой. М.: МИА, 2011. 480 с.
2. Богданов Э.И., Талантов В.В., Мухамедзянов Р.З. Диабетические нейропатии. Вестник неврологии, 2000, 3-4: 59-67.
3. Гурьева И.В., Комелягина Е.Ю., Кузина И.В. и др. Диабетическая периферическая сенсомоторная нейропатия. Методические рекомендации. М., 2000.
4. Коновалова Е.Ю. Классификация природных соединений. Новые подходы на современном этапе. Фундаментальные исследования, 2012, 8(Часть 1): 197-203.
5. Мирошниченко И.И., Птицына С.Н., Кузнецова Н.Н., Калмыков Ю.М. Гомоцистеин – предиктор патологических изменений в организме человека. РМЖ, 2009, 4.
6. Маев И.В., Казюлин А.Н., Белый П.А. Витамины. М.: МЕДпресс-информ, 2011. 544 с.
7. Brownlee M. The pathobiology of diabetic complications. A unifying mechanism. Diabetes, 2005, 54: 1615-1625.
8. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature, 2001, 414: 813-820.
9. Thornalley PJ. Glyoxalase I. Structure, function, and a critical role in the enzymatic defence against glycation. Biochem Soc Trans, 2003, 31: 1343-1348.
10. The Diabetes Control and Complications Trial Research Group.(DCCT)The effect of intensive treatment of diabetes on the developmentand progression of long-term complications in insulin-dependentdiabetes mellitus. N Engl J Med, 1993, 329: 977-86.
11. UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 1998, 352: 837-5.
12. Du X, Edelstein D, Brownlee M. Oral benfotiamine plus α-ipoic acid normalises complication-causing pathways in type 1 diabetes. Diabetologia, 2008, 51: 1930-1932.
13. Dyck PJ, Kratz КМ, Kames JL et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in apopulation-based cohort. The Rochester Diabetic Neuropathy Study. Neurology, 1993, 43: 817-30.
14. Ewing DJ, Martin CN, Young RJ, Clarke BF. the value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care, 1985, 8(5): 491-498.
15. The ACCORD-EYE study results. Сахарный диабет, 2010, 2.
16. The ACCORD Study Group. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med, 2011, 364: 818-828.
Review
For citations:
Podachina SV. VITAMINS. PREVENTION AND TREATMENT OF COMPLICATIONS IN PATIENTS WITH DIABETES MELLITUS. Meditsinskiy sovet = Medical Council. 2017;(3):95-98. (In Russ.) https://doi.org/10.21518/2079-701X-2017-3-95-98
Views:
812
Email this article 